Business Context and Reporting Period
Company: Protalix Biotherapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Reporting Date: July 1, 2008
Event: The Company announced its inclusion in the Russell Microcap Index.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses solely on a corporate event and does not contain financial statements or performance data.
Material Changes
Index Inclusion: On July 1, 2008, Protalix Biotherapeutics, Inc. was added to the Russell Microcap Index. This is a change in market classification rather than a change in operational or financial performance.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. The document serves strictly to disclose the index inclusion event.
Investor Verification Checklist
- Verify the effective date of inclusion in the Russell Microcap Index.
- Review the attached press release (Exhibit 99.1) for any additional context regarding the index addition.
- Consult the Company's most recent 10-Q or 10-K for actual financial performance metrics, as they are absent from this 8-K.